InsuSense

Insulin-dependent diabetes is a disease of constant management. Every meal, every workout, every stressful day requires a manual decision: how much insulin, when, delivered how. Mistakes have serious consequences. The cognitive and physical burden on patients is enormous.

InsuSense started with a simple question: what if the system could close the loop?

The prototype integrates with continuous glucose monitors (CGMs) to read real-time glucose data and trigger insulin delivery automatically — a step toward a closed-loop artificial pancreas system. The core engineering challenge was building a delivery mechanism that's reliable, miniaturized, and safe enough to trust with medication.

This project required going deep on both the biology and the engineering simultaneously. I had to understand how glucose-insulin dynamics actually work — lag times, correction factors, carb ratios — before I could design a system that wouldn't over- or under-dose.

The research phase alone was one of the most intensive I've done. The clinical constraints on any device that touches medication delivery are strict for good reason. This project gave me enormous respect for the people who build medical devices professionally.